An Open-Label, Fixed Sequence, Two-Period Study to Investigate the Effect of RO7049389 on the Pharmacokinetics of Pitavastatin in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 10 Jan 2020
Price : $35 *
At a glance
- Drugs RO 7049389 (Primary) ; Pitavastatin
- Indications Hepatitis B
- Focus Pharmacokinetics
- Sponsors Roche
- 11 Feb 2019 Status changed from active, no longer recruiting to completed.
- 19 Nov 2018 Status changed to active, no longer recruiting.
- 29 Oct 2018 New trial record